About
Simmunome provides a no-code, high-fidelity SaaS platform that uses AI-driven disease simulations integrating protein networks, multi-omics data, and clinical evidence to support drug development decisions and clinical trial patient stratification.
Explore Simmunome's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.